NCT01285544View on ClinicalTrials.gov

The Efficacy and Tolerability of Two Formulations of Atorvastatin In Korean Adult With Hypercholesterolemia

PHASE4CompletedINTERVENTIONAL
Enrollment

289

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

July 31, 2009

Study Completion Date

July 31, 2009

Conditions
DyslipidemiaCardiovascular DiseaseHypercholesterolemia
Interventions
DRUG

Atorvastatin (Lipinon)

treatment of dyslipidemia administration : PO, qod

DRUG

Atorvastatin (Lipitor)

treatment of dyslipidemia administration : PO, qod

Trial Locations (1)

Unknown

Seoul National University Hospital, Seoul

Sponsors

Collaborators (1)

Dong-A Pharmaceutical
All Listed Sponsors
collaborator

Dong-A Pharmaceutical

INDUSTRY

lead

Seoul National University Hospital

OTHER

NCT01285544 - The Efficacy and Tolerability of Two Formulations of Atorvastatin In Korean Adult With Hypercholesterolemia | Biotech Hunter | Biotech Hunter